Antineoplaston Therapy

Antineoplaston therapy — including auto‑urine therapy, oral antineoplastons, associated physician services, monitoring labs/imaging, infusion pumps/IV supplies, and Hickman catheter placement — is considered experimental/investigational, not FDA‑approved, and is excluded from coverage. There are no covered indications or approval criteria that would allow payment for antineoplaston therapy.

"None — antineoplaston therapy is considered experimental and investigational and is not established as effective for any indication."

Sign up to see full coverage criteria, indications, and limitations.